News
Gum Disease Linked to Heart Risk!
United States: Periodontitis is really a very serious gum disease that literally cause chronic inflammation around your teeth due to the dirty bacteria in the mouth. If not treated, it can lead to tooth loss and more, making it really important to take care of your gums.
On the other hand, this thrombosis particularly happens when blood clots form and block blood flow in your body. This can ultimately lead to symptoms like pain and swelling which is like in extreme cases, it can be very dangerous and even life-threatening. Both conditions highlight the importance of keeping our bodies and mouths healthy!
As reported by the news-medical.net, Periodontitis has been associated with thrombosis using processes related to systemic inflammation or bacteria transfer and modulation of platelet function and coagulation. The present case also appears to suggest that periodontal treatment can potentially have a protective effect on thrombotic disease patients.
Porphyromonas gingivalis, Tannerella forsythia, T. denticola, A. actinomycetemcomitans and F. nucleatum are pathogens that cause periodontal infections and compromise the periodontium, which is the connective tissue supporting the teeth. Other periodontal infections like P. gingivalis are transported in the bloodstream from periodontal pockets to colonize other body organs.

These infections generate toxins which lead to systemic inflammation and conditions that increase the likelihood for thrombotic disease. Endothelial barrier can be impaired by systemic inflammation raising coagulability, blood flow velocity, and stressing immune cells involved in plateleting. One or more of the factors highlighted by Virchow can be expected to directly trigger arterial thrombosis as well as venous thromboembolism.
A relationship of periodontistic disease with thrombotic disease has ideas evidence because periodontits is associated with increased levels of thrombotic factors like fibrinogen and elevated hemocyte activity.
Furthermore, periodontal inflammation creates a microbial shift in the stomach. Intestinal dysbiosis increases trimethylamine N-oxide (TMAO) that in turn lead to atherosclerosis. Some of the diseases associated with periodontitis include atherosclerosis, endothelial dysfunction and leukocyte recruits that harbor bacteria.

Previous research has identified periodontal bacteria in carotid atherosclerotic plaques and thrombotic clot in patient treated with percutaneous coronary intervention (PCI). The results of a study show that TAO patients have more frequent periodontitis and higher antibody levels against periodontal pathogens.
Some patients with severe periodontal diseases may have features of cardiovascular disease such as increased arterial rigidity, reduced FMD, and elevated cIMT.
The association of periodontitis in thrombotic diseases concerning the onset, severity, and prognosis has been established. Diagnosis of periodontitis enhances the risk of cardiovascular disease and thrombosis through platelet abnormalities that lead to hyperactivation of the blood coagulation system.
Periodontitis exacerbates the clinical outcomes in the thrombosis incidents however, periodontal treatment enhances the endothelial cell function and the prognosis which stimulates platelet activation via toll-like receptor 2 and also the TLR4 signaling.
News
Painless Skin Patch Offers New Immunization Alternative
United States: According to experts, children who dislike immunization needles may soon have a painless skin patch as an alternative. Following a single vaccination dosage via the patch, all 190 Gambian infants were protected against rubella and more than 90% of them were protected against measles, according to preliminary study data.
According to experts, the patch has a variety of tiny needles that enter the skin gently and administer the vaccination.
Potential Impact on Global Immunization Efforts
“These are really encouraging results that have created a lot of enthusiasm, even if it’s early days. “They show for the first time that microarray patch technology can be used to safely and effectively administer vaccines to babies and young children,” said Ed Clarke, a researcher and head of infant immunology at the London School of Hygiene & Tropical Medicine’s Medical Research Council Unit The Gambia.
“Vaccines against measles are the most important to administer using this method, but it is also now feasible to administer other vaccines using microarray patches,” stated Clarke. “Pay attention to this area.”
Scaling Up Trials and Advancing Vaccine Delivery

According to experts, these patches may facilitate the expansion of immunization coverage in less developed nations. They don’t require a medical practitioner to give them, may be simpler to carry, and may not require cold storage.
Speaking for the Medical Research Council Unit The Gambia at the London School of Hygiene & Tropical Medicine, Dr. Ikechukwu Adigweme stated, “We hope this is an important step in the march towards greater vaccine equity among disadvantaged populations.”
Addressing Parental Concerns in Wealthy Nations
According to academics, vaccination patches may be a more convenient and painless option for traditional jabs in wealthy nations like the US.
According to them, providing a patch-based immunization might even persuade more parents to vaccinate their children.
Due to parental vaccination hesitation, the United States has seen outbreaks of the extremely contagious and lethal virus throughout the previous several years, despite the measles being declared eliminated in 2000.
The researchers noted that in order to validate these findings and offer further information, larger trials of the patches are currently being developed.
News
Climate Change Fuels Dangerous Germs in Our Food.
United States: Experts are warning that warmer temperatures are affecting our food and making it less safe. Recently, there was an outbreak of E. coli linked to McDonald’s Quarter Pounders, which can make people sick.
Scientists say that germs, like the bacteria that cause E. coli, are changing because of climate change. Pratik Banerjee, a food safety teacher at the University of Illinois, explains that these changes can be bad for our health.
Banerjee is at the moment employed to analyze the effects of climate on food production.
As reported by Yahoo.com, “Again I said to her there is not a magic wand that can be there and the food would be absolutely safe, right?” he said. ‘Thus, it is to minimize the risk’.
Comparable work is underway at the Institute for Food Safety in the Illinois Institute of Technology.
‘This is probably disrupting a whole lot of the large context out there with regards to how microorganisms go about their day,’ IFSH’s Dr Alvin Lee adds.
The FDA reports that the Slivered onions that are used to garnish on the Quarter Pounders are likely the cause of the E. coli to bring an outbreak at McDonalds. But, in a sense, if you talked to people with whom CBS News Chicago spoke to for this piece, the McDonald’s outbreak is as real as climate change.
’Those that are skeptics, they will be believers after a while,” said attorney Bill Marler of Marler Clark, The Food Safety Law Firm, ‘There are many more scientific papers out there that are coming out with reports that show that certain pathogens such as E.coli, salmonella and campylobacter are better suited for heat than we are.’
Marler has acted as a lawyer for victims of outbreaks across the country for more than three decades as a foodborne illness lawyer. He said that some of these pathogens which cause food to be contaminated are being found in the United States for the first-time courtesy of climate change.
Some of the bugs you find here in United States countries we have never seen any. We do not usually used to see Cyclospora as bacterial or viral issue. Now, we are seeing it all the time in the United States, and that’s because temperatures are warming,” he said. Once in a while, it was more of a South American issue. Now, it’s a U.S. problem.”
He said given that temperature affects pathogens that are in the food chain, there is need to adapt in the industry.
News
How Do mRNA Boosters Strengthen Your Nose’s Immunity?
United States: During the COVID pandemic, many people got several mRNA vaccines to protect themselves. Researchers from the VIB-UGent Center for Inflammation Research, Ghent University, and University Hospital Ghent studied these vaccines and discovered something interesting.
They found that getting vaccinated multiple times helps create special antibodies in our bodies, especially in places like the nose. This research was shared in a science journal called Science Translational Medicine.
One of the global response strategies to the COVID pandemic is the provision of booster doses, or what the world refers to as vaccine updates, in an effort to protect the population against emerging strains of SARS-CoV-2.

As reported by Medicalxpress.com, the work done by the researchers was aimed at understanding the impact of a range of mRNA vaccines on the mucosal immunity these are the surfaces including those within ournasal cavity. Focusing on these populations, the study employed 183 participants who were selected at different post-primary and booster vaccination times.
Ph.D. student Jozefien Declercq (VIB-UGent) said, “Our studies showed that mRNA boosters increased the neutralising antibodies in respiratory secretions many fold.” Not only that, but immune responses induced by the mRNA vaccines may remain more durable than previously estimated, and this would bode well for long-term immunity against novel maladaptive mutations of the virus.
But how, you may ask, do the antibodies produced in response to the vaccine get the heck to the nose?

According to Prof. Dr. Stijn Vanhee from VIB-UGent, a co-senior author of the study. In a mouse study, we found that most of the neutralizing antibodies originated in the systemic immune system, antibodies that circulate in the blood seem to move to the respiratory mucosa in the nose, further, repeated vaccination creates antibodies in the peripheral areas which circulate to the mucosal sites.
The studies indicate that booster doses not only strengthen the immunity of the organism on the whole but also increase the production of mucosal antibodies, which will be a more effective barrier to the virus.
Prof. Dr. Linos Vandekerckhove (Ghent University), co-senior author of the study, emphasizes the critical role of mucosal immunity in the fight against COVID-19: This is a very useful study for demonstrating that boost mRNA vaccinations can increase mucosal antibody production, or rev up an infection-induced mucosal response which is critical for virus blocking at the access points.
